✦ LIBER ✦

P-452 Phase III study of docetaxel-cisplatin (DC) or docetaxel-carboplatin (DCb) versus vinorelbine-cisplatin (VC) as first-line treatment of advanced non-small cell lung cancer (NSCLC): Analyses by gender

✍ Scribed by Belani, C.; von Pawel, J.; Pluzanska, A.; Gorbounova, V.; Kaukel, E.; Mattson, K.; Ramlau, R.; Fidias, P.; Millward, M.; Fossella, F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-51 Phase III study (TAX 326) of doceta

✍ Belani, Chandra P.; Fossella, Frank V. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

A multicenter, randomized phase III stud

✍ Belani, C.P; Rodriguez, J; von Pawel, J; Pluzanska, A; Gorbounova, V; Millward, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Docetaxel + Cisplatin (DC) and Docetaxel

✍ F. Fossella 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 140 KB

776 An economic analysis of the TAX 326

✍ N. Leighl; F.A. Shepherd; W.S. Tsao; P. Lindgren; C.B. Belani; F.V. Fossella; P. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Randomised multicenter phase II study of

✍ Novello, Silvia; Falcone, Alfredo; Crinò, Lucio; Rinaldi, Massimo; Nardi, Mario; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 360 KB

nCombination chemotherapy with docetaxel

✍ Georgoulias, Vassilis; Androulakis, Nikos; Bouros, Demosthenis; Kouroussis, Char 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 87 KB